{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:07:52Z","timestamp":1790968072383,"version":"4.1.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIH NIDDK","award":["U01DK127551"],"award-info":[{"award-number":["U01DK127551"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Children with type 1 diabetes and their caregivers face numerous challenges navigating the unpredictability of this complex disease. Although the burden of managing diabetes remains significant, new technology has eased some of the load and allowed children with type 1 diabetes to achieve tighter glycaemic management without fear of excess hypoglycaemia. Continuous glucose monitor use alone improves outcomes and is considered standard of care for paediatric type 1 diabetes management. Similarly, automated insulin delivery (AID) systems have proven to be safe and effective for children as young as 2 years of age. AID use improves not only blood glucose levels but also quality of life for children with type 1 diabetes and their caregivers and should be strongly considered for all youth with type 1 diabetes if available and affordable. Here, we review key data on the use of diabetes technology in the paediatric population and discuss management issues unique to children and adolescents.<\/jats:p>","DOI":"10.1007\/s00125-024-06218-0","type":"journal-article","created":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:02:04Z","timestamp":1720746124000},"page":"2075-2084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Use of diabetes technology in children"],"prefix":"10.1007","volume":"67","author":[{"given":"Melissa J.","family":"Schoelwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"DeBoer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc D.","family":"Breton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"issue":"8","key":"6218_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jamapediatrics.2023.2029","volume":"177","author":"K Zhang","year":"2023","unstructured":"Zhang K, Kan C, Han F et al (2023) Global, regional, and national epidemiology of diabetes in children from 1990 to 2019. JAMA Pediatr 177(8):837\u2013846. https:\/\/doi.org\/10.1001\/jamapediatrics.2023.2029","journal-title":"JAMA Pediatr"},{"issue":"8","key":"6218_CR2","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1001\/jama.2021.11165","volume":"326","author":"JM Lawrence","year":"2021","unstructured":"Lawrence JM, Divers J, Isom S et al (2021) Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001\u20132017. JAMA 326(8):717\u2013727. https:\/\/doi.org\/10.1001\/jama.2021.11165","journal-title":"JAMA"},{"issue":"10146","key":"6218_CR3","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/s0140-6736(18)31506-x","volume":"392","author":"A Rawshani","year":"2018","unstructured":"Rawshani A, Sattar N, Franz\u00e9n S et al (2018) Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. Lancet (London, England) 392(10146):477\u2013486. https:\/\/doi.org\/10.1016\/s0140-6736(18)31506-x","journal-title":"Lancet (London, England)"},{"issue":"4 Pt 2","key":"6218_CR4","first-page":"S19","volume":"27","author":"CL Acerini","year":"2001","unstructured":"Acerini CL, Williams RM, Dunger DB (2001) Metabolic impact of puberty on the course of type 1 diabetes. Diabetes Metab 27(4 Pt 2):S19-25","journal-title":"Diabetes Metab"},{"key":"6218_CR5","doi-asserted-by":"publisher","first-page":"110678","DOI":"10.1016\/j.diabres.2023.110678","volume":"199","author":"P Michou","year":"2023","unstructured":"Michou P, Gkiourtzis N, Christoforidis A, Kotanidou EP, Galli-Tsinopoulou A (2023) The efficacy of automated insulin delivery systems in children and adolescents with type 1 diabetes Mellitus: A systematic review and meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 199:110678. https:\/\/doi.org\/10.1016\/j.diabres.2023.110678","journal-title":"Diabetes Res Clin Pract"},{"issue":"12","key":"6218_CR6","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.2337\/dc23-0504","volume":"46","author":"B Zeng","year":"2023","unstructured":"Zeng B, Gao L, Yang Q, Jia H, Sun F (2023) Automated insulin delivery systems in children and adolescents with type 1 diabetes: a systematic review and meta-analysis of outpatient randomized controlled trials. Diabetes Care 46(12):2300\u20132307. https:\/\/doi.org\/10.2337\/dc23-0504","journal-title":"Diabetes Care"},{"issue":"16","key":"6218_CR7","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.3390\/ijerph191610293","volume":"19","author":"B Bombaci","year":"2022","unstructured":"Bombaci B, Passanisi S, Alibrandi A et al (2022) One-year real-world study on comparison among different continuous subcutaneous insulin infusion devices for the management of pediatric patients with type 1 diabetes: the supremacy of hybrid closed-loop systems. Int J Environ Res Public Health 19(16):10293. https:\/\/doi.org\/10.3390\/ijerph191610293","journal-title":"Int J Environ Res Public Health"},{"issue":"5","key":"6218_CR8","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.2337\/dc20-1674","volume":"44","author":"R Cardona-Hernandez","year":"2021","unstructured":"Cardona-Hernandez R, Schwandt A, Alkandari H et al (2021) Glycemic outcome associated with insulin pump and glucose sensor use in children and adolescents with type 1 diabetes. Data from the international pediatric registry SWEET. Diabetes Care 44(5):1176\u20131184. https:\/\/doi.org\/10.2337\/dc20-1674","journal-title":"Diabetes Care"},{"issue":"3\u20134","key":"6218_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000517352","volume":"94","author":"M Nevo-Shenker","year":"2021","unstructured":"Nevo-Shenker M, Shalitin S (2021) The impact of hypo- and hyperglycemia on cognition and brain development in young children with type 1 diabetes. Horm Res Paediatr 94(3\u20134):115\u2013123. https:\/\/doi.org\/10.1159\/000517352","journal-title":"Horm Res Paediatr"},{"issue":"7","key":"6218_CR10","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.2337\/db14-0348","volume":"63","author":"GJ Biessels","year":"2014","unstructured":"Biessels GJ, Reijmer YD (2014) Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI? Diabetes 63(7):2244\u20132252. https:\/\/doi.org\/10.2337\/db14-0348","journal-title":"Diabetes"},{"issue":"4","key":"6218_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2337\/dc20-2125","volume":"44","author":"N Mauras","year":"2021","unstructured":"Mauras N, Buckingham B, White NH et al (2021) Impact of type 1 diabetes in the developing brain in children: a longitudinal study. Diabetes Care 44(4):983\u2013992. https:\/\/doi.org\/10.2337\/dc20-2125","journal-title":"Diabetes Care"},{"issue":"2","key":"6218_CR12","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2337\/dc20-1978","volume":"44","author":"MJ Redondo","year":"2021","unstructured":"Redondo MJ, Libman I, Maahs DM et al (2021) The evolution of hemoglobin A(1c) targets for youth with type 1 diabetes: rationale and supporting evidence. Diabetes Care 44(2):301\u2013312. https:\/\/doi.org\/10.2337\/dc20-1978","journal-title":"Diabetes Care"},{"issue":"Supplement_1","key":"6218_CR13","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.2337\/dc24-S014","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2023","unstructured":"American Diabetes Association Professional Practice Committee (2023) 14. Children and adolescents: standards of care in diabetes\u20142024. Diabetes Care 47(Supplement_1):S258\u2013S281. https:\/\/doi.org\/10.2337\/dc24-S014","journal-title":"Diabetes Care"},{"issue":"8","key":"6218_CR14","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1111\/pedi.13455","volume":"23","author":"M de Bock","year":"2022","unstructured":"de Bock M, Codner E, Craig ME et al (2022) ISPAD Clinical Practice Consensus Guidelines 2022: Glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes. Pediatr Diabetes 23(8):1270\u20131276. https:\/\/doi.org\/10.1111\/pedi.13455","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"6218_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1089\/dia.2018.0384","volume":"21","author":"NC Foster","year":"2019","unstructured":"Foster NC, Beck RW, Miller KM et al (2019) State of type 1 diabetes management and outcomes from the T1D exchange in 2016\u20132018. Diabetes Technol Ther 21(2):66\u201372. https:\/\/doi.org\/10.1089\/dia.2018.0384","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"6218_CR16","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2337\/dci19-0028","volume":"42","author":"T Battelino","year":"2019","unstructured":"Battelino T, Danne T, Bergenstal RM et al (2019) Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care 42(8):1593\u20131603. https:\/\/doi.org\/10.2337\/dci19-0028","journal-title":"Diabetes Care"},{"issue":"9","key":"6218_CR17","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1089\/dia.2021.0097","volume":"23","author":"MD Breton","year":"2021","unstructured":"Breton MD, Kovatchev BP (2021) One year real-world use of the control-IQ advanced hybrid closed-loop technology. Diabetes Technol Ther 23(9):601\u2013608. https:\/\/doi.org\/10.1089\/dia.2021.0097","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"6218_CR18","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2337\/dc21-1666","volume":"45","author":"SR Johnson","year":"2022","unstructured":"Johnson SR, Holmes-Walker DJ, Chee M et al (2022) Universal subsidized continuous glucose monitoring funding for young people with type 1 diabetes: uptake and outcomes over 2 years, a population-based study. Diabetes Care 45(2):391\u2013397. https:\/\/doi.org\/10.2337\/dc21-1666","journal-title":"Diabetes Care"},{"issue":"6","key":"6218_CR19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2337\/dc22-2121","volume":"46","author":"GT Alonso","year":"2023","unstructured":"Alonso GT, Triolo TM, Akturk HK et al (2023) Increased technology use associated with lower A1C in a large pediatric clinical population. Diabetes Care 46(6):1218\u20131222. https:\/\/doi.org\/10.2337\/dc22-2121","journal-title":"Diabetes Care"},{"issue":"1","key":"6218_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2337\/cd23-0052","volume":"42","author":"P Prahalad","year":"2024","unstructured":"Prahalad P, Hardison H, Odugbesan O et al (2024) Benchmarking diabetes technology use among 21 U.S. Pediatric diabetes centers. Clin Diabetes 42(1):27\u201333. https:\/\/doi.org\/10.2337\/cd23-0052","journal-title":"Clin Diabetes"},{"issue":"13","key":"6218_CR21","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1001\/jama.2016.11708","volume":"316","author":"RM Bergenstal","year":"2016","unstructured":"Bergenstal RM, Garg S, Weinzimer SA et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA 316(13):1407\u20131408. https:\/\/doi.org\/10.1001\/jama.2016.11708","journal-title":"JAMA"},{"issue":"10155","key":"6218_CR22","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/s0140-6736(18)31947-0","volume":"392","author":"M Tauschmann","year":"2018","unstructured":"Tauschmann M, Thabit H, Bally L et al (2018) Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial. Lancet (London, England) 392(10155):1321\u20131329. https:\/\/doi.org\/10.1016\/s0140-6736(18)31947-0","journal-title":"Lancet (London, England)"},{"issue":"18","key":"6218_CR23","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","volume":"381","author":"SA Brown","year":"2019","unstructured":"Brown SA, Kovatchev BP, Raghinaru D et al (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381(18):1707\u20131717. https:\/\/doi.org\/10.1056\/NEJMoa1907863","journal-title":"N Engl J Med"},{"issue":"9","key":"6218_CR24","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1056\/NEJMoa2004736","volume":"383","author":"MD Breton","year":"2020","unstructured":"Breton MD, Kanapka LG, Beck RW et al (2020) A randomized trial of closed-loop control in children with type 1 diabetes. N Engl J Med 383(9):836\u2013845. https:\/\/doi.org\/10.1056\/NEJMoa2004736","journal-title":"N Engl J Med"},{"issue":"7","key":"6218_CR25","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.2337\/dc21-0172","volume":"44","author":"SA Brown","year":"2021","unstructured":"Brown SA, Forlenza GP, Bode BW et al (2021) Multicenter trial of a tubeless, on-body automated insulin delivery system with customizable glycemic targets in pediatric and adult participants with type 1 diabetes. Diabetes Care 44(7):1630\u20131640. https:\/\/doi.org\/10.2337\/dc21-0172","journal-title":"Diabetes Care"},{"issue":"3","key":"6218_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1089\/dia.2021.0319","volume":"24","author":"AL Carlson","year":"2022","unstructured":"Carlson AL, Sherr JL, Shulman DI et al (2022) Safety and glycemic outcomes during the minimed\u2122 advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes. Diabetes Technol Ther 24(3):178\u2013189. https:\/\/doi.org\/10.1089\/dia.2021.0319","journal-title":"Diabetes Technol Ther"},{"issue":"13","key":"6218_CR27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1056\/NEJMoa2205225","volume":"387","author":"SJ Russell","year":"2022","unstructured":"Russell SJ, Beck RW, Damiano ER et al (2022) Multicenter, randomized trial of a bionic pancreas in type 1 diabetes. N Engl J Med 387(13):1161\u20131172. https:\/\/doi.org\/10.1056\/NEJMoa2205225","journal-title":"N Engl J Med"},{"issue":"4","key":"6218_CR28","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/s2589-7500(22)00020-6","volume":"4","author":"J Ware","year":"2022","unstructured":"Ware J, Boughton CK, Allen JM et al (2022) Cambridge hybrid closed-loop algorithm in children and adolescents with type 1 diabetes: a multicentre 6-month randomised controlled trial. Lancet Digit Health 4(4):e245\u2013e255. https:\/\/doi.org\/10.1016\/s2589-7500(22)00020-6","journal-title":"Lancet Digit Health"},{"issue":"1","key":"6218_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/pedi.12230","volume":"17","author":"DR Chernavvsky","year":"2016","unstructured":"Chernavvsky DR, DeBoer MD, Keith-Hynes P et al (2016) Use of an artificial pancreas among adolescents for a missed snack bolus and an underestimated meal bolus. Pediatr Diabetes 17(1):28\u201335. https:\/\/doi.org\/10.1111\/pedi.12230","journal-title":"Pediatr Diabetes"},{"issue":"S3","key":"6218_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/dia.2023.0505","volume":"26","author":"BA Buckingham","year":"2024","unstructured":"Buckingham BA, Bergenstal RM (2024) Decreasing the burden of carbohydrate counting and meal announcement with automated insulin delivery, meal recognition, and autocorrection doses: a case study. Diabetes Technol Ther 26(S3):97\u2013101. https:\/\/doi.org\/10.1089\/dia.2023.0505","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"6218_CR31","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.2337\/dc22-1217","volume":"45","author":"BP Kovatchev","year":"2022","unstructured":"Kovatchev BP, Singh H, Mueller L, Gonder-Frederick LA (2022) Biobehavioral changes following transition to automated insulin delivery: a large real-life database analysis. Diabetes Care 45(11):2636\u20132643. https:\/\/doi.org\/10.2337\/dc22-1217","journal-title":"Diabetes Care"},{"issue":"7","key":"6218_CR32","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1089\/dia.2020.0646","volume":"23","author":"MJ Schoelwer","year":"2021","unstructured":"Schoelwer MJ, Kanapka LG, Wadwa RP et al (2021) Predictors of time-in-range (70\u2013180 mg\/dL) achieved using a closed-loop control system. Diabetes Technol Ther 23(7):475\u2013481. https:\/\/doi.org\/10.1089\/dia.2020.0646","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"6218_CR33","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.2337\/dc21-0740","volume":"44","author":"A Dehn-Hindenberg","year":"2021","unstructured":"Dehn-Hindenberg A, Sa\u00dfmann H, Berndt V et al (2021) Long-term occupational consequences for families of children with type 1 diabetes: the mothers take the burden. Diabetes Care 44(12):2656\u20132663. https:\/\/doi.org\/10.2337\/dc21-0740","journal-title":"Diabetes Care"},{"issue":"8","key":"6218_CR34","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.2337\/dc21-2359","volume":"45","author":"JL Sherr","year":"2022","unstructured":"Sherr JL, Bode BW, Forlenza GP et al (2022) Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial. Diabetes Care 45(8):1907\u20131910. https:\/\/doi.org\/10.2337\/dc21-2359","journal-title":"Diabetes Care"},{"issue":"3","key":"6218_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1111\/pedi.13312","volume":"23","author":"GP Forlenza","year":"2022","unstructured":"Forlenza GP, Ekhlaspour L, DiMeglio LA et al (2022) Glycemic outcomes of children 2\u20136 years of age with type 1 diabetes during the pediatric MiniMed\u2122 670G system trial. Pediatr Diabetes 23(3):324\u2013329. https:\/\/doi.org\/10.1111\/pedi.13312","journal-title":"Pediatr Diabetes"},{"issue":"3","key":"6218_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa2111673","volume":"386","author":"J Ware","year":"2022","unstructured":"Ware J, Allen JM, Boughton CK et al (2022) Randomized trial of closed-loop control in very young children with type 1 diabetes. N Engl J Med 386(3):209\u2013219. https:\/\/doi.org\/10.1056\/NEJMoa2111673","journal-title":"N Engl J Med"},{"issue":"11","key":"6218_CR37","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa2210834","volume":"388","author":"RP Wadwa","year":"2023","unstructured":"Wadwa RP, Reed ZW, Buckingham BA et al (2023) Trial of hybrid closed-loop control in young children with type 1 diabetes. N Engl J Med 388(11):991\u20131001. https:\/\/doi.org\/10.1056\/NEJMoa2210834","journal-title":"N Engl J Med"},{"issue":"5","key":"6218_CR38","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1177\/1932296820929420","volume":"15","author":"EM Youngkin","year":"2021","unstructured":"Youngkin EM, Majidi S, Noser AE, Stanek KR, Clements MA, Patton SR (2021) Continuous glucose monitoring decreases hypoglycemia avoidance behaviors, but not worry in parents of youth with new onset type 1 diabetes. J Diabetes Sci Technol 15(5):1093\u20131097. https:\/\/doi.org\/10.1177\/1932296820929420","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"6218_CR39","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/pedi.12872","volume":"20","author":"G Musolino","year":"2019","unstructured":"Musolino G, Dovc K, Boughton CK et al (2019) Reduced burden of diabetes and improved quality of life: experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes. Pediatr Diabetes 20(6):794\u2013799. https:\/\/doi.org\/10.1111\/pedi.12872","journal-title":"Pediatr Diabetes"},{"key":"6218_CR40","doi-asserted-by":"publisher","first-page":"111114","DOI":"10.1016\/j.diabres.2024.111114","volume":"208","author":"KK Hood","year":"2024","unstructured":"Hood KK, Schneider-Utaka AK, Reed ZW et al (2024) Patient reported outcomes (PROs) and user experiences of young children with type 1 diabetes using t:slim X2 insulin pump with control-IQ technology. Diabetes Res Clin Pract 208:111114. https:\/\/doi.org\/10.1016\/j.diabres.2024.111114","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"6218_CR41","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.2337\/dc21-1778","volume":"45","author":"EC Cobry","year":"2022","unstructured":"Cobry EC, Bisio A, Wadwa RP, Breton MD (2022) Improvements in parental sleep, fear of hypoglycemia, and diabetes distress with use of an advanced hybrid closed-loop system. Diabetes Care 45(5):1292\u20131295. https:\/\/doi.org\/10.2337\/dc21-1778","journal-title":"Diabetes Care"},{"issue":"12","key":"6218_CR42","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.2337\/dc22-0693","volume":"45","author":"C de Beaufort","year":"2022","unstructured":"de Beaufort C, Schierloh U, Thankamony A et al (2022) Cambridge hybrid closed-loop system in very young children with type 1 diabetes reduces caregivers\u2019 fear of hypoglycemia and improves their well-being. Diabetes Care 45(12):3050\u20133053. https:\/\/doi.org\/10.2337\/dc22-0693","journal-title":"Diabetes Care"},{"key":"6218_CR43","doi-asserted-by":"publisher","first-page":"109877","DOI":"10.1016\/j.diabres.2022.109877","volume":"187","author":"B Kimbell","year":"2022","unstructured":"Kimbell B, Rankin D, Hart RI et al (2022) Parents\u2019 experiences of using a hybrid closed-loop system (CamAPS FX) to care for a very young child with type 1 diabetes: qualitative study. Diabetes Res Clin Pract 187:109877. https:\/\/doi.org\/10.1016\/j.diabres.2022.109877","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"6218_CR44","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/1742395320985924","volume":"18","author":"D Rankin","year":"2022","unstructured":"Rankin D, Kimbell B, Hovorka R, Lawton J (2022) Adolescents\u2019 and their parents\u2019 experiences of using a closed-loop system to manage type 1 diabetes in everyday life: qualitative study. Chronic Illn 18(4):742\u2013756. https:\/\/doi.org\/10.1177\/1742395320985924","journal-title":"Chronic Illn"},{"issue":"10","key":"6218_CR45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/dia.2023.0238","volume":"25","author":"J Weissberg-Benchell","year":"2023","unstructured":"Weissberg-Benchell J, Vesco AT, Shapiro J et al (2023) Psychosocial impact of the insulin-only iLet bionic pancreas for adults, youth, and caregivers of youth with type 1 diabetes. Diabetes Technol Ther 25(10):705\u2013717. https:\/\/doi.org\/10.1089\/dia.2023.0238","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"6218_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1089\/dia.2020.0532","volume":"23","author":"EC Cobry","year":"2021","unstructured":"Cobry EC, Kanapka LG, Cengiz E et al (2021) Health-related quality of life and treatment satisfaction in parents and children with type 1 diabetes using closed-loop control. Diabetes Technol Ther 23(6):401\u2013409. https:\/\/doi.org\/10.1089\/dia.2020.0532","journal-title":"Diabetes Technol Ther"},{"key":"6218_CR47","doi-asserted-by":"publisher","first-page":"967725","DOI":"10.3389\/fendo.2022.967725","volume":"13","author":"A Gianini","year":"2022","unstructured":"Gianini A, Suklan J, Skela-Savi\u010d B et al (2022) Patient reported outcome measures in children and adolescents with type 1 diabetes using advanced hybrid closed loop insulin delivery. Front Endocrinol (Lausanne) 13:967725. https:\/\/doi.org\/10.3389\/fendo.2022.967725","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"6218_CR48","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/pedi.12962","volume":"21","author":"C Berget","year":"2020","unstructured":"Berget C, Messer LH, Vigers T et al (2020) Six months of hybrid closed loop in the real-world: an evaluation of children and young adults using the 670G system. Pediatr Diabetes 21(2):310\u2013318. https:\/\/doi.org\/10.1111\/pedi.12962","journal-title":"Pediatr Diabetes"},{"issue":"6","key":"6218_CR49","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1089\/dia.2022.0491","volume":"25","author":"F Lombardo","year":"2023","unstructured":"Lombardo F, Passanisi S, Alibrandi A et al (2023) MiniMed 780G six-month use in children and adolescents with type 1 diabetes: clinical targets and predictors of optimal glucose control. Diabetes Technol Ther 25(6):404\u2013413. https:\/\/doi.org\/10.1089\/dia.2022.0491","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"6218_CR50","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1089\/dia.2021.0165","volume":"23","author":"LH Messer","year":"2021","unstructured":"Messer LH, Berget C, Pyle L et al (2021) Real-world use of a new hybrid closed loop improves glycemic control in youth with type 1 diabetes. Diabetes Technol Ther 23(12):837\u2013843. https:\/\/doi.org\/10.1089\/dia.2021.0165","journal-title":"Diabetes Technol Ther"},{"key":"6218_CR51","doi-asserted-by":"publisher","unstructured":"Arunachalum S, Velado K, Vigersky RA, Cordero TL (2022) Glycemic outcomes during real-world hybrid closed-loop system use by individuals with type 1 diabetes in the United States. J Diabetes Sci Technol 19322968221088608. https:\/\/doi.org\/10.1177\/19322968221088608","DOI":"10.1177\/19322968221088608"},{"issue":"2","key":"6218_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/dia.2021.0203","volume":"24","author":"JD Silva","year":"2022","unstructured":"Silva JD, Lepore G, Battelino T et al (2022) Real-world performance of the MiniMed\u2122 780G system: first report of outcomes from 4120 users. Diabetes Technol Ther 24(2):113\u2013119. https:\/\/doi.org\/10.1089\/dia.2021.0203","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"6218_CR53","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1111\/pedi.13421","volume":"23","author":"JL Sherr","year":"2022","unstructured":"Sherr JL, Schoelwer M, Dos Santos TJ et al (2022) ISPAD clinical practice consensus guidelines 2022: diabetes technologies: insulin delivery. Pediatr Diabetes 23(8):1406\u20131431. https:\/\/doi.org\/10.1111\/pedi.13421","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"6218_CR54","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1089\/dia.2019.0142","volume":"21","author":"ME Hilliard","year":"2019","unstructured":"Hilliard ME, Levy W, Anderson BJ et al (2019) Benefits and barriers of continuous glucose monitoring in young children with type 1 diabetes. Diabetes Technol Therap 21(9):493\u2013498. https:\/\/doi.org\/10.1089\/dia.2019.0142","journal-title":"Diabetes Technol Therap"},{"issue":"5","key":"6218_CR55","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1111\/pedi.13015","volume":"21","author":"CA March","year":"2020","unstructured":"March CA, Nanni M, Kazmerski TM, Siminerio LM, Miller E, Libman IM (2020) Modern diabetes devices in the school setting: perspectives from school nurses. Pediatr Diabetes 21(5):832\u2013840. https:\/\/doi.org\/10.1111\/pedi.13015","journal-title":"Pediatr Diabetes"},{"issue":"10","key":"6218_CR56","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1056\/NEJMoa2203496","volume":"387","author":"CK Boughton","year":"2022","unstructured":"Boughton CK, Allen JM, Ware J et al (2022) Closed-loop therapy and preservation of C-peptide secretion in type 1 diabetes. N Engl J Med 387(10):882\u2013893. https:\/\/doi.org\/10.1056\/NEJMoa2203496","journal-title":"N Engl J Med"},{"issue":"12","key":"6218_CR57","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1001\/jama.2023.2063","volume":"329","author":"J McVean","year":"2023","unstructured":"McVean J, Forlenza GP, Beck RW et al (2023) Effect of tight glycemic control on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial. JAMA 329(12):980\u2013989. https:\/\/doi.org\/10.1001\/jama.2023.2063","journal-title":"JAMA"},{"issue":"3","key":"6218_CR58","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/dia.2023.0307","volume":"26","author":"R Lakshman","year":"2024","unstructured":"Lakshman R, Najami M, Allen JM et al (2024) Diabetic ketoacidosis at onset of type 1 diabetes and glycemic outcomes with closed-loop insulin delivery. Diabetes Technol Ther 26(3):198\u2013202. https:\/\/doi.org\/10.1089\/dia.2023.0307","journal-title":"Diabetes Technol Ther"},{"key":"6218_CR59","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2147\/mder.S312858","volume":"14","author":"ME Pauley","year":"2021","unstructured":"Pauley ME, Berget C, Messer LH, Forlenza GP (2021) Barriers to uptake of insulin technologies and novel solutions. Med Devices (Auckl) 14:339\u2013354. https:\/\/doi.org\/10.2147\/mder.S312858","journal-title":"Med Devices (Auckl)"},{"issue":"4","key":"6218_CR60","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41390-019-0665-4","volume":"87","author":"M Nevo-Shenker","year":"2020","unstructured":"Nevo-Shenker M, Phillip M, Nimri R, Shalitin S (2020) Type 1 diabetes mellitus management in young children: implementation of current technologies. Pediatr Res 87(4):624\u2013629. https:\/\/doi.org\/10.1038\/s41390-019-0665-4","journal-title":"Pediatr Res"},{"issue":"11","key":"6218_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11892-018-1078-1","volume":"18","author":"GP Forlenza","year":"2018","unstructured":"Forlenza GP, Messer LH, Berget C, Wadwa RP, Driscoll KA (2018) Biopsychosocial factors associated with satisfaction and sustained use of artificial pancreas technology and its components: a call to the technology field. Curr Diab Rep 18(11):114. https:\/\/doi.org\/10.1007\/s11892-018-1078-1","journal-title":"Curr Diab Rep"},{"issue":"4","key":"6218_CR62","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1177\/1932296816651450","volume":"10","author":"T Kubiak","year":"2016","unstructured":"Kubiak T, Mann CG, Barnard KC, Heinemann L (2016) Psychosocial aspects of continuous glucose monitoring: connecting to the patients\u2019 experience. J Diabetes Sci Technol 10(4):859\u2013863. https:\/\/doi.org\/10.1177\/1932296816651450","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"6218_CR63","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/dme.13568","volume":"35","author":"LH Messer","year":"2018","unstructured":"Messer LH, Johnson R, Driscoll KA, Jones J (2018) Best friend or spy: a qualitative meta-synthesis on the impact of continuous glucose monitoring on life with Type 1 diabetes. Diabet Med 35(4):409\u2013418. https:\/\/doi.org\/10.1111\/dme.13568","journal-title":"Diabet Med"},{"issue":"1","key":"6218_CR64","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2337\/dc22-0525","volume":"46","author":"F Gomez-Peralta","year":"2023","unstructured":"Gomez-Peralta F, Abreu C, Fern\u00e1ndez-Rubio E et al (2023) Efficacy of a connected insulin pen cap in people with noncontrolled type 1 diabetes: a multicenter randomized clinical trial. Diabetes Care 46(1):206\u2013208. https:\/\/doi.org\/10.2337\/dc22-0525","journal-title":"Diabetes Care"},{"issue":"1","key":"6218_CR65","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s13300-021-01177-w","volume":"13","author":"P Adolfsson","year":"2022","unstructured":"Adolfsson P, Bj\u00f6rnsson V, Hartvig NV, Kaas A, M\u00f8ller JB, Ogionwo Lange E (2022) Improved glycemic control observed in children with type 1 diabetes following the introduction of smart insulin pens: a real-world study. Diabetes Ther 13(1):43\u201356. https:\/\/doi.org\/10.1007\/s13300-021-01177-w","journal-title":"Diabetes Ther"},{"issue":"2","key":"6218_CR66","doi-asserted-by":"publisher","first-page":"e002537","DOI":"10.1136\/bmjdrc-2021-002537","volume":"9","author":"TJ Dos Santos","year":"2021","unstructured":"Dos Santos TJ, Dave C, MacLeish S, Wood JR (2021) Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey. BMJ Open Diabetes Res Care 9(2):e002537. https:\/\/doi.org\/10.1136\/bmjdrc-2021-002537","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"6218_CR67","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2337\/dc20-0257","volume":"44","author":"A Addala","year":"2021","unstructured":"Addala A, Auzanneau M, Miller K et al (2021) A decade of disparities in diabetes technology use and HbA(1c) in pediatric type 1 diabetes: a transatlantic comparison. Diabetes Care 44(1):133\u2013140. https:\/\/doi.org\/10.2337\/dc20-0257","journal-title":"Diabetes Care"},{"issue":"3","key":"6218_CR68","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/dia.2021.0326","volume":"24","author":"GP Forlenza","year":"2022","unstructured":"Forlenza GP, Vigers T, Berget C et al (2022) Predicting success with a first-generation hybrid closed-loop artificial pancreas system among children, adolescents, and young adults with type 1 diabetes: a model development and validation study. Diabetes Technol Ther 24(3):157\u2013166. https:\/\/doi.org\/10.1089\/dia.2021.0326","journal-title":"Diabetes Technol Ther"},{"key":"6218_CR69","doi-asserted-by":"publisher","unstructured":"Fox DS, Ware J, Boughton CK et al (2024) Cost-effectiveness of closed-loop automated insulin delivery using the Cambridge hybrid algorithm in children and adolescents with type 1 diabetes: results from a multicenter 6-month randomized trial. J Diabetes Sci Technol 19322968241231950. https:\/\/doi.org\/10.1177\/19322968241231950","DOI":"10.1177\/19322968241231950"},{"issue":"7","key":"6218_CR70","doi-asserted-by":"publisher","first-page":"807","DOI":"10.18553\/jmcp.2023.22331","volume":"29","author":"JE Biskupiak","year":"2023","unstructured":"Biskupiak JE, Ramos M, Levy CJ et al (2023) Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States. J Manag Care Spec Pharm 29(7):807\u2013817. https:\/\/doi.org\/10.18553\/jmcp.2023.22331","journal-title":"J Manag Care Spec Pharm"},{"issue":"9","key":"6218_CR71","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/dia.2021.0075","volume":"23","author":"S Agarwal","year":"2021","unstructured":"Agarwal S, Crespo-Ramos G, Long JA, Miller VA (2021) \u201cI didn\u2019t really have a choice\u201d: qualitative analysis of racial-ethnic disparities in diabetes technology use among young adults with type 1 diabetes. Diabetes Technol Ther 23(9):616\u2013622. https:\/\/doi.org\/10.1089\/dia.2021.0075","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"6218_CR72","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1177\/19322968211006476","volume":"15","author":"A Addala","year":"2021","unstructured":"Addala A, Hanes S, Naranjo D, Maahs DM, Hood KK (2021) Provider implicit bias impacts pediatric type 1 diabetes technology recommendations in the united states: findings from the gatekeeper study. J Diabetes Sci Technol 15(5):1027\u20131033. https:\/\/doi.org\/10.1177\/19322968211006476","journal-title":"J Diabetes Sci Technol"},{"issue":"11","key":"6218_CR73","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1089\/dia.2021.0120","volume":"23","author":"CW Lai","year":"2021","unstructured":"Lai CW, Lipman TH, Willi SM, Hawkes CP (2021) Early racial\/ethnic disparities in continuous glucose monitor use in pediatric type 1 diabetes. Diabetes Technol Ther 23(11):763\u2013767. https:\/\/doi.org\/10.1089\/dia.2021.0120","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"6218_CR74","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1056\/NEJMe2209840","volume":"387","author":"SA Brown","year":"2022","unstructured":"Brown SA (2022) On the path toward expanding treatment options for diabetes. N Engl J Med 387(10):935\u2013936. https:\/\/doi.org\/10.1056\/NEJMe2209840","journal-title":"N Engl J Med"},{"issue":"6","key":"6218_CR75","doi-asserted-by":"publisher","first-page":"e121","DOI":"10.2337\/dc20-3063","volume":"44","author":"HK Akturk","year":"2021","unstructured":"Akturk HK, Agarwal S, Hoffecker L, Shah VN (2021) Inequity in racial-ethnic representation in randomized controlled trials of diabetes technologies in type 1 diabetes: critical need for new standards. Diabetes Care 44(6):e121\u2013e123. https:\/\/doi.org\/10.2337\/dc20-3063","journal-title":"Diabetes Care"},{"issue":"10","key":"6218_CR76","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1089\/dia.2023.0197","volume":"25","author":"J Garc\u00eda-Tirado","year":"2023","unstructured":"Garc\u00eda-Tirado J, Villard O, Hall M, Bisio A, Gonder-Frederick L (2023) Under-representation of diverse populations and glycemic outcomes in major clinical trials of automated insulin delivery. Diabetes Technol Ther 25(10):752\u2013754. https:\/\/doi.org\/10.1089\/dia.2023.0197","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"6218_CR77","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1111\/dom.14737","volume":"24","author":"JP Corbett","year":"2022","unstructured":"Corbett JP, Hsu L, Brown SA et al (2022) Smartwatch gesture-based meal reminders improve glycaemic control. Diabetes Obes Metab 24(8):1667\u20131670. https:\/\/doi.org\/10.1111\/dom.14737","journal-title":"Diabetes Obes Metab"},{"key":"6218_CR78","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-0932","author":"J Garcia-Tirado","year":"2021","unstructured":"Garcia-Tirado J, Diaz JL, Esquivel-Zuniga R et al (2021) Advanced closed-loop control system improves postprandial glycemic control compared with a hybrid closed-loop system following unannounced meal. Diabetes Care. https:\/\/doi.org\/10.2337\/dc21-0932","journal-title":"Diabetes Care"},{"issue":"9","key":"6218_CR79","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.2337\/dc23-0119","volume":"46","author":"J Garcia-Tirado","year":"2023","unstructured":"Garcia-Tirado J, Colmegna P, Villard O et al (2023) Assessment of meal anticipation for improving fully automated insulin delivery in adults with type 1 diabetes. Diabetes Care 46(9):1652\u20131658. https:\/\/doi.org\/10.2337\/dc23-0119","journal-title":"Diabetes Care"},{"issue":"3","key":"6218_CR80","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2337\/dc20-2106","volume":"44","author":"H Blauw","year":"2021","unstructured":"Blauw H, Onvlee AJ, Klaassen M, van Bon AC, DeVries JH (2021) Fully closed loop glucose control with a bihormonal artificial pancreas in adults with type 1 diabetes: an outpatient, randomized, crossover trial. Diabetes Care 44(3):836\u2013838. https:\/\/doi.org\/10.2337\/dc20-2106","journal-title":"Diabetes Care"},{"issue":"4","key":"6218_CR81","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1089\/dia.2020.0516","volume":"23","author":"J Garcia-Tirado","year":"2021","unstructured":"Garcia-Tirado J, Brown SA, Laichuthai N et al (2021) Anticipation of historical exercise patterns by a novel artificial pancreas system reduces hypoglycemia during and after moderate-intensity physical activity in people with type 1 diabetes. Diabetes Technol Ther 23(4):277\u2013285. https:\/\/doi.org\/10.1089\/dia.2020.0516","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"6218_CR82","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/pedi.12454","volume":"18","author":"MD DeBoer","year":"2017","unstructured":"DeBoer MD, Cher\u00f1avvsky DR, Topchyan K, Kovatchev BP, Francis GL, Breton MD (2017) Heart rate informed artificial pancreas system enhances glycemic control during exercise in adolescents with T1D. Pediatr Diabetes 18(7):540\u2013546. https:\/\/doi.org\/10.1111\/pedi.12454","journal-title":"Pediatr Diabetes"},{"issue":"5","key":"6218_CR83","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1089\/dia.2017.0424","volume":"20","author":"GP Forlenza","year":"2018","unstructured":"Forlenza GP, Cameron FM, Ly TT et al (2018) Fully closed-loop multiple model probabilistic predictive controller artificial pancreas performance in adolescents and adults in a supervised hotel setting. Diabetes Technol Ther 20(5):335\u2013343. https:\/\/doi.org\/10.1089\/dia.2017.0424","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"6218_CR84","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1089\/dia.2023.0042","volume":"25","author":"J Ware","year":"2023","unstructured":"Ware J, Allen JM, Boughton CK et al (2023) Hybrid closed-loop with faster insulin aspart compared with standard insulin aspart in very young children with type 1 diabetes: a double-blind, multicenter, randomized, crossover study. Diabetes Technol Ther 25(6):431\u2013436. https:\/\/doi.org\/10.1089\/dia.2023.0042","journal-title":"Diabetes Technol Ther"},{"issue":"9","key":"6218_CR85","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1089\/dia.2023.0178","volume":"25","author":"K Dovc","year":"2023","unstructured":"Dovc K, Bergford S, Fr\u00f6hlich-Reiterer E et al (2023) A comparison of faster insulin aspart with standard insulin aspart using hybrid automated insulin delivery system in active children and adolescents with type 1 diabetes: a randomized double-blind crossover trial. Diabetes Technol Ther 25(9):612\u2013621. https:\/\/doi.org\/10.1089\/dia.2023.0178","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"6218_CR86","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1177\/1932296820928067","volume":"15","author":"P Colmegna","year":"2021","unstructured":"Colmegna P, Cengiz E, Garcia-Tirado J, Kraemer K, Breton MD (2021) Impact of accelerating insulin on an artificial pancreas system without meal announcement: an in silico examination. J Diabetes Sci Technol 15(4):833\u201341. https:\/\/doi.org\/10.1177\/1932296820928067","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"6218_CR87","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/19322968221140401","volume":"18","author":"P Colmegna","year":"2024","unstructured":"Colmegna P, Diaz CJL, Garcia-Tirado J, DeBoer MD, Breton MD (2024) Adjusting therapy profiles when switching to ultra-rapid lispro in an advanced hybrid closed-loop system: an in silico study. J Diabetes Sci Technol 18(3):676\u201385. https:\/\/doi.org\/10.1177\/19322968221140401","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"6218_CR88","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1089\/dia.2022.0468","volume":"25","author":"CJL Diaz","year":"2023","unstructured":"Diaz CJL, Colmegna P, Breton MD (2023) Maximizing glycemic benefits of using faster insulin formulations in type 1 diabetes: in silico analysis under open-and closed-loop conditions. Diabetes Technol Ther 25(4):219\u201330. https:\/\/doi.org\/10.1089\/dia.2022.0468","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"6218_CR89","doi-asserted-by":"publisher","first-page":"597","DOI":"10.2337\/dc19-1922","volume":"43","author":"A Haidar","year":"2020","unstructured":"Haidar A, Tsoukas MA, Bernier-Twardy S et al (2020) A novel dual-hormone insulin-and-pramlintide artificial pancreas for type 1 diabetes: a randomized controlled crossover trial. Diabetes Care 43(3):597\u2013606. https:\/\/doi.org\/10.2337\/dc19-1922","journal-title":"Diabetes Care"},{"issue":"10","key":"6218_CR90","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1056\/NEJMc2302677","volume":"389","author":"P Dandona","year":"2023","unstructured":"Dandona P, Chaudhuri A, Ghanim H (2023) Semaglutide in early type 1 diabetes. N Engl J Med 389(10):958\u2013959. https:\/\/doi.org\/10.1056\/NEJMc2302677","journal-title":"N Engl J Med"},{"issue":"7","key":"6218_CR91","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/dia.2021.0542","volume":"24","author":"J Garcia-Tirado","year":"2022","unstructured":"Garcia-Tirado J, Farhy L, Nass R et al (2022) Automated insulin delivery with SGLT2i combination therapy in type 1 diabetes. Diabetes Technol Ther 24(7):461\u2013470. https:\/\/doi.org\/10.1089\/dia.2021.0542","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"6218_CR92","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1177\/19322968211008185","volume":"15","author":"S Alva","year":"2021","unstructured":"Alva S, Castorino K, Cho H, Ou J (2021) Feasibility of continuous ketone monitoring in subcutaneous tissue using a ketone sensor. J Diabetes Sci Technol 15(4):768\u2013774. https:\/\/doi.org\/10.1177\/19322968211008185","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"6218_CR93","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s2213-8587(17)30167-5","volume":"5","author":"A Weisman","year":"2017","unstructured":"Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA (2017) Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol 5(7):501\u2013512. https:\/\/doi.org\/10.1016\/s2213-8587(17)30167-5","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"6218_CR94","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1016\/s2589-7500(24)00002-5","volume":"6","author":"AC van Bon","year":"2024","unstructured":"van Bon AC, Blauw H, Jansen TJP et al (2024) Bihormonal fully closed-loop system for the treatment of type 1 diabetes: a real-world multicentre, prospective, single-arm trial in the Netherlands. Lancet Digit Health 6(4):e272\u2013e280. https:\/\/doi.org\/10.1016\/s2589-7500(24)00002-5","journal-title":"Lancet Digit Health"},{"issue":"5","key":"6218_CR95","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s13300-023-01401-9","volume":"14","author":"MD DeBoer","year":"2023","unstructured":"DeBoer MD, Valdez R, Corbett JP et al (2023) Effect of an automated advice algorithm (CloudConnect) on adolescent-parent diabetes-specific communication and glycemic management: a randomized trial. Diabetes Ther 14(5):899\u2013913. https:\/\/doi.org\/10.1007\/s13300-023-01401-9","journal-title":"Diabetes Ther"},{"issue":"6","key":"6218_CR96","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.2196\/mhealth.7336","volume":"5","author":"S Goyal","year":"2017","unstructured":"Goyal S, Nunn CA, Rotondi M et al (2017) A mobile app for the self-management of type 1 diabetes among adolescents: a randomized controlled trial. JMIR Mhealth Uhealth 5(6):e82. https:\/\/doi.org\/10.2196\/mhealth.7336","journal-title":"JMIR Mhealth Uhealth"},{"issue":"1","key":"6218_CR97","doi-asserted-by":"publisher","first-page":"186","DOI":"10.2337\/dc21-0838","volume":"45","author":"A Bisio","year":"2022","unstructured":"Bisio A, Anderson S, Norlander L et al (2022) Impact of a novel diabetes support system on a cohort of individuals with type 1 diabetes treated with multiple daily injections: a multicenter randomized study. Diabetes Care 45(1):186\u2013193. https:\/\/doi.org\/10.2337\/dc21-0838","journal-title":"Diabetes Care"},{"issue":"6","key":"6218_CR98","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/dme.13090","volume":"33","author":"PJ O'Connor","year":"2016","unstructured":"O\u2019Connor PJ, Sperl-Hillen JM, Fazio CJ, Averbeck BM, Rank BH, Margolis KL (2016) Outpatient diabetes clinical decision support: current status and future directions. Diabet Med 33(6):734\u2013741. https:\/\/doi.org\/10.1111\/dme.13090","journal-title":"Diabet Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06218-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-024-06218-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06218-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T10:03:46Z","timestamp":1727863426000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-024-06218-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":98,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["6218"],"URL":"https:\/\/doi.org\/10.1007\/s00125-024-06218-0","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All authors are funded by grant U01DK127551 from NIH NIDDK.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"MJS reports research funding, paid to her university, from Tandem Diabetes Care and Insulet. MDD reports research funding paid to his university from Dexcom Inc, Tandem Diabetes Inc and Medtronic. MDB reports research funding paid to his university from Dexcom, Tandem Diabetes Care and Novo Nordisk, and non-financial research support from Tandem Diabetes Care and Dexcom. Additionally, MDB has a number of patents with royalties licensed to Dexcom, Sanofi, Tandem Diabetes Care and Novo Nordisk. MDB finally reports consulting\/speakership activities with Dexcom, Tandem Diabetes Care, Roche, Portal Insulin LLC, BoydSense and Vertex.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"All authors were responsible for drafting this review article and reviewing it critically for important intellectual content. All authors approved the version to be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}